|
GNS expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.78028999999746E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.41310000000428E-05 |
| Normal-vs-Stage2 |
6.719800E-02 |
| Normal-vs-Stage3 |
4.4565000000274E-06 |
| Normal-vs-Stage4 |
2.88530000003284E-07 |
| Stage1-vs-Stage2 |
1.333830E-01 |
| Stage1-vs-Stage3 |
2.420400E-01 |
| Stage1-vs-Stage4 |
5.039700E-02 |
| Stage2-vs-Stage3 |
3.201900E-02 |
| Stage2-vs-Stage4 |
5.541100E-03 |
| Stage3-vs-Stage4 |
3.173600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.55400999999333E-05 |
| Normal-vs-AfricanAmerican |
6.760000E-03 |
| Normal-vs-Asian |
1.383890E-04 |
| Caucasian-vs-AfricanAmerican |
7.415000E-01 |
| Caucasian-vs-Asian |
8.526600E-01 |
| AfricanAmerican-vs-Asian |
6.425600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.77760000017602E-07 |
| Normal-vs-Female |
9.99619999999535E-05 |
| Male-vs-Female |
1.219630E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.970600E-04 |
| Normal-vs-Age(41-60Yrs) |
8.41600000023313E-07 |
| Normal-vs-Age(61-80Yrs) |
6.824500E-04 |
| Normal-vs-Age(81-100Yrs) |
4.180600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.847770E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.881400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.814800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.536800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.601000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.813200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.008400E-01 |
| Classical-VS-Follicular |
1.817970E-01 |
| Classical-VS-Other |
5.932000E-02 |
| Classical-VS-Normal |
2.29519999994654E-06 |
| Tall-VS-Follicular |
3.264300E-02 |
| Tall-VS-Other |
1.638800E-01 |
| Tall-VS-Normal |
1.86416999999883E-05 |
| Follicular-VS-Other |
8.080500E-03 |
| Follicular-VS-Normal |
2.505700E-02 |
| Other-VS-Normal |
2.842100E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.994100E-04 |
| Normal-vs-N1 |
3.51100000184346E-08 |
| N0-vs-N1 |
8.061300E-03 |
|
|
